Cetuximab - Latest Advances

Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.

Journal: Otolaryngologic clinics of North America

Published: October 04, 2025

Prediction of Severe Skin Disorders Induced by Anti-epidermal Growth Factor Receptor Antibody Drugs

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: October 01, 2025

Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies.

Journal: Tumor discovery

Published: September 29, 2025

Detection and warning of drug-induced hypomagnesemia: a pharmacovigilance study of the FDA Adverse Event Reporting System.

Journal: Magnesium research

Published: September 26, 2025

Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A Review.

Journal: JAMA oncology

Published: September 25, 2025

Unraveling the role of PREX2 mutations as a biomarker for immunotherapy response in colorectal cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: September 19, 2025

Comparison of the Anticancer Effects of a Complementary Peptide for Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3) With Conventional Anticancer Drugs in the Treatment of Oral Squamous Cell Carcinoma: A Pilot Study.

Journal: Cureus

Published: September 04, 2025

1,2-Naphthoquinone promotes cell migration through EGFR-ERK signaling pathway in human A549 cells.

Journal: The Journal of toxicological sciences

Published: August 31, 2025

The Development of Malignant Melanoma Concurrent to Encorafenib and Cetuximab Therapy for Gastrointestinal Cancer With Neuroendocrine Features.

Journal: South Dakota medicine : the journal of the South Dakota State Medical Association

Published: August 29, 2025

Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade.

Journal: The British journal of dermatology

Published: August 17, 2025

Safety and costs of dose banding of high-priced drugs for cancer treatments. First Argentine experience

Journal: Medicina

Published: August 12, 2025

Surface plasmon resonance microscopy reveals N-glycosylation driven modulation of affinity and avidity of ErbB receptors in whole single pancreatic cancer cells.

Journal: Glycobiology

Published: August 12, 2025

Filters

Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.

Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.

Prediction of Severe Skin Disorders Induced by Anti-epidermal Growth Factor Receptor Antibody Drugs

Prediction of Severe Skin Disorders Induced by Anti-epidermal Growth Factor Receptor Antibody Drugs

Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies.

Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies.

Detection and warning of drug-induced hypomagnesemia: a pharmacovigilance study of the FDA Adverse Event Reporting System.

Detection and warning of drug-induced hypomagnesemia: a pharmacovigilance study of the FDA Adverse Event Reporting System.

Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A Review.

Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A Review.

Unraveling the role of PREX2 mutations as a biomarker for immunotherapy response in colorectal cancer.

Unraveling the role of PREX2 mutations as a biomarker for immunotherapy response in colorectal cancer.

Comparison of the Anticancer Effects of a Complementary Peptide for Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3) With Conventional Anticancer Drugs in the Treatment of Oral Squamous Cell Carcinoma: A Pilot Study.

Comparison of the Anticancer Effects of a Complementary Peptide for Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3) With Conventional Anticancer Drugs in the Treatment of Oral Squamous Cell Carcinoma: A Pilot Study.

1,2-Naphthoquinone promotes cell migration through EGFR-ERK signaling pathway in human A549 cells.

1,2-Naphthoquinone promotes cell migration through EGFR-ERK signaling pathway in human A549 cells.

The Development of Malignant Melanoma Concurrent to Encorafenib and Cetuximab Therapy for Gastrointestinal Cancer With Neuroendocrine Features.

The Development of Malignant Melanoma Concurrent to Encorafenib and Cetuximab Therapy for Gastrointestinal Cancer With Neuroendocrine Features.

Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade.

Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade.

Safety and costs of dose banding of high-priced drugs for cancer treatments. First Argentine experience

Safety and costs of dose banding of high-priced drugs for cancer treatments. First Argentine experience

Surface plasmon resonance microscopy reveals N-glycosylation driven modulation of affinity and avidity of ErbB receptors in whole single pancreatic cancer cells.

Surface plasmon resonance microscopy reveals N-glycosylation driven modulation of affinity and avidity of ErbB receptors in whole single pancreatic cancer cells.